Wyeth Sues Sandoz Over Contraceptive Patent

Law360, New York (May 30, 2008, 12:00 AM EDT) -- Wyeth has sued another rival for infringing its patent for contraceptive Lybrel, this time filing a lawsuit against Sandoz Inc.

In a lawsuit filed Wednesday in the U.S. District Court for the District of Delaware, Wyeth said that Sandoz filed an abbreviated new drug application that infringes on its patent for the drug.

The patent, U.S. Patent No. 6,500,814, was issued in December 2002 and “relates to a hormonal contraceptive product having two hormonal components, an estrogen and a gestagen, and a process for the combined,...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.